Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Afr Health Sci ; 20(4): 1742-1748, 2020 Dec.
Article in English | MEDLINE | ID: mdl-34394234

ABSTRACT

BACKGROUND: Cardiovascular abnormalities are not much reported among human immunodeficiency virus (HIV) infected children especially in Africa where there is high HIV disease. In addition, the use of highly active antiretroviral therapy (HAART) in such children may have a protective effect on the cardiovascular system. METHODS: Cross-sectional study of randomly selected eighty HIV infected and 80 aged matched non- HIV-infected children were used. HIV-infected children were on HAART for more than 5years and had steadily received the treatment for 6 months prior to the time of the tests. Heights and weights were measured and body mass index calculated. Cardiac indices evaluated were heart rate (HR), PR interval, QRS duration, QT/QTC Interval, P/QRS/T Axis, RV5/SV1 voltage and RV5+SV1 voltage. RESULTS: The average heart rate was significantly higher among HIV infected children on HAART than their non-infected counterparts (P= 0.019). At 0.05 significance level, their PR interval was significantly higher than those in the control group (P=0.050). The average QRS duration result also showed a significant difference between that of test and control subjects (P = 0.022). CONCLUSION: The HAART usage possibly improved the cardiovascular functioning in the infected children but the protective effects diminish with increase age and longer exposure.


Subject(s)
Antiretroviral Therapy, Highly Active/adverse effects , Arrhythmias, Cardiac/diagnosis , Electrocardiography/methods , HIV Infections/drug therapy , Infectious Disease Transmission, Vertical , Arrhythmias, Cardiac/epidemiology , Body Mass Index , Child , Cross-Sectional Studies , HIV Infections/complications , HIV Infections/epidemiology , Heart Rate/physiology , Humans , Male , Nigeria
2.
J Physiol Sci ; 67(1): 227-234, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27221151

ABSTRACT

Hibiscus sabdariffa (HS) has been traditionally used as a herbal medicine in Nigeria mainly because of its antihypertensive action. In view of the recent increase in the prevalence of renal failure, we have investigated the effect of HS consumption on renal function in Nigerians with mild to moderate hypertension. A total of 78 newly diagnosed but untreated subjects with mild to moderate hypertension attending the medical outpatients unit of Enugu State University Teaching Hospital (Enugu, Nigeria) were recruited for the study. These subjects were randomly divided into three equally sized groups that received HS or lisinopril (treatment groups) or placebo (control group), once daily for 4 weeks. Indices of renal function (urine volume and creatinine clearance) were measured at baseline and weekly throughout the study period. HS and lisinopril significantly increased (P < 0.001) urine volume compared to placebo, and HS significantly (P < 0.001) increased urine volume more than lisinopril. HS significantly increased (P < 0.001) creatinine clearance compared to placebo whereas lisinopril did not. These results indicate that HS consumption improved indices of renal function in our study population of Nigerians with mild to moderate hypertension.


Subject(s)
Antihypertensive Agents/pharmacokinetics , Hypertension/physiopathology , Kidney/drug effects , Lisinopril/pharmacology , Plant Extracts/pharmacology , Adult , Aged , Blood Pressure/drug effects , Creatinine/metabolism , Female , Hibiscus , Humans , Kidney/physiopathology , Male , Middle Aged , Phytotherapy , Treatment Outcome
3.
Indian J Pharmacol ; 47(5): 540-5, 2015.
Article in English | MEDLINE | ID: mdl-26600645

ABSTRACT

OBJECTIVES: The present study investigated the effects of aqueous extract of Hibiscus sabdariffa (HS) on the three basic components of renin-angiotensin-aldosterone system: Plasma renin, serum angiotensin-converting enzyme (ACE), and plasma aldosterone (PA) in mild to moderate essential hypertensive Nigerians and compared with that of lisinopril, an ACE inhibitor. MATERIALS AND METHODS: A double-blind controlled randomized clinical study was used. Seventy-eight newly diagnosed but untreated mild to moderate hypertensive subjects attending Medical Outpatients Clinic of Enugu State University Teaching Hospital, Enugu were recruited for the study. Those in Group A received placebo (150 mg/kg/day), Group B were given lisinopril (10 mg once daily) while those in Group C received aqueous extract of HS (150 mg/kg/day). After 4 weeks of treatment, the levels of plasma renin, serum ACE, and PA were determined. RESULTS: HS and lisinopril significantly (P < 0.001) reduced PA compared to placebo by 32.06% and 30.01%, respectively. Their effects on serum ACE and plasma renin activity (PRA) were not significant compared to placebo; they reduced ACE by 6.63% and 5.67% but increased plasma PRA by 2.77% and 5.36%, respectively. CONCLUSION: HS reduced serum ACE and PA in mild to moderate hypertensive Nigerians with equal efficacy as lisinopril. These actions are possibly due to the presence of anthocyanins in the extract.


Subject(s)
Antihypertensive Agents/therapeutic use , Hibiscus/chemistry , Hypertension/drug therapy , Plant Extracts/therapeutic use , Adult , Aged , Aldosterone/blood , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Antihypertensive Agents/pharmacology , Double-Blind Method , Essential Hypertension , Humans , Hypertension/physiopathology , Lisinopril/pharmacology , Lisinopril/therapeutic use , Middle Aged , Nigeria , Peptidyl-Dipeptidase A/blood , Plant Extracts/pharmacology , Renin/blood , Renin-Angiotensin System/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...